Page 37 - Material Command News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Material command. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Material Command Today - Breaking & Trending Today

CytoSorbents Awarded $1.5 Million Sequential Phase II SBIR Contract to Advance the Treatment of Severe Hyperkalemia in Traumatic Injury

Share this article
Share this article
MONMOUTH JUNCTION, N.J., May 11, 2021 /PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a critical care leader commercializing its CytoSorb® and other blood purification technologies to treat deadly conditions in critically-ill and cardiac surgery patients around the world, announced the U.S Army Medical Research and Development Command has awarded CytoSorbents a Defense Health Agency (DHA) Sequential Phase II Small Business Innovation Research (SBIR) contract, valued at $1,499,987 over 28 months, to advance development of the K
+ontrol™ platform for the treatment of severe hyperkalemia induced by traumatic injury and acute kidney injury in austere medicine. This follows the successful completion of the previously announced Phase I and Phase II SBIR programs for this application, totaling approximately $1.15 million in previous contract funding. ....

United States , Eric Kim , Amy Vogel , Material Command , Defense Health Agency Sequential Phase , National Research Council , European Union , Us Army , United States Army Medical Research , Blood Institute , National Heart , Cytosorbents Corporation , Development Command , Us Army Medical Research Acquisition , Laboratory Animals , National Institutes Of Health , Human Services , Us Department Of Health , Us Air , Department Of The Army , Medical Research Acquisition , Animal Welfare Act Regulations , National Research , Sorbents Corporation , Use Authorization , National Institutes ,

Researchers discover new class of cancer fighting compounds

Date Time
Researchers discover new class of cancer fighting compounds
CORVALLIS, Ore. – A team of Oregon State University scientists has discovered a new class of anti-cancer compounds that effectively kill liver and breast cancer cells.
The findings, recently published in the journal Apoptosis, describe the discovery and characterization of compounds, designated as Select Modulators of AhR-regulated Transcription (SMAhRTs).
Edmond Francis O’Donnell III and a team of OSU researchers conducted the research in the laboratory of Siva Kolluri, a professor of cancer research at Oregon State. They also identified the aryl hydrocarbon receptor (AhR) as a new molecular target for development of cancer therapeutics. ....

Oregon State University , United States , Nancy Kerkvliet , Daniel Liefwalker , Siva Kolluri , Edmond Francis Odonnell , Science University , Oregon State Linus Pauling Institute , Department Of Defense Breast Cancer Research Program , National Cancer Institute , National Institute Of Environmental Health Sciences , Translational Environmental Health Research , Pacific Northwest Center , Us Army Medical Research , Oregon Health , Department Of Environmental , American Cancer Society , Uc Davis Medical Center , College Of Agricultural Sciences , Select Modulators , Ahr Regulated Transcription , Molecular Toxicology , Fas Ligand , Medical Center , Hyo Sang Jang , Oregon State ,

CytoSorbents Reports First Quarter 2021 Financial and Operational Results

CytoSorbents Reports First Quarter 2021 Financial and Operational Results
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

United States , New Jersey , State Of New Jersey , Michael Mack , Eric Kim , Amy Vogel , Phillip Chan , C Michael Gibson , Us Department Of Health , Human Services , Material Command , National Institutes Of Health , Us Air , Company Form , Development Expenses , Clinical Evaluation Committee , European Union , Us Army , Cytosorbents Corporation , National Heart , Blood Institute , Cytosorbents Continues Healthy Sales Growth , Employee Retention Tax Credit , Chief Executive Officer , Latin America , Middle East ,

60 planeloads of US military equipment leave Afghanistan as drawdown begins, CENTCOM says

By COREY DICKSTEIN | STARS AND STRIPES Published: May 4, 2021
ATLANTA U.S. military officials said they had removed some 60 planeloads of gear from Afghanistan and identified about 1,300 pieces of equipment for destruction by Tuesday as the Pentagon works to exit the country where American troops have been at war for nearly 20 years.
The drawdown effort to remove U.S. forces and the warfighting gear that they have spread across Afghanistan since invading in October 2001 was roughly 2% to 6% completed by Tuesday, U.S. Central Command said in a statement. The formal retrograde process began Saturday as the Pentagon works to remove more than 3,000 troops, thousands of U.S. contractors and their equipment by Sept. 11, the date that President Joe Biden decided he wanted all American forces to be out of the country. ....

United States , Donald Trump , Barack Obama , Curt Higdon , Joe Biden , Army Material , Army Afghan , Afghan National Army , President Joe Biden , Camp New Antonik , Army Material Command , Redstone Arsenal , Presidents Barack Obama , Material Command , ஒன்றுபட்டது மாநிலங்களில் , டொனால்ட் துருப்பு , பராக் ஒபாமா , ஓஹோ பிடென் , இராணுவம் பொருள் , ப்ரெஸிடெஂட் ஓஹோ பிடென் , இராணுவம் பொருள் கட்டளை , ரெட்ஸ்டோன் ஆயுதக் களஞ்சியம் , ப்ரெஸிடெஂட்ஸ் பராக் ஒபாமா , பொருள் கட்டளை ,

CytoSorbents to Report Q1 2021 Operating and Financial Results

CytoSorbents to Report Q1 2021 Operating and Financial Results
News provided by
Share this article
Share this article
MONMOUTH JUNCTION, N.J., April 27, 2021 /PRNewswire/ CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, will report Q1 2021 financial results after the market close on Tuesday, May 4, 2021 at 4:45PM EST.
CytoSorbents management will host a live conference call and presentation webcast that will recount both operational and financial progress during Q1 2021 followed by a question and answer session.
CytoSorbents Corporation to Report Q1 2021 Operating and Financial Results on Tuesday, May 4, 2021 ....

United States , Eric Kim , Amy Vogel , Us Department Of Health , Human Services , Material Command , National Institutes Of Health , Us Air , Breakthrough Devices Program , European Union , Us Army , Blood Institute , Cytosorbents Corporation , National Heart , Conference Call Details , Presentation Webcast , Investor Relations , Sorbents Corporation , Use Authorization , National Institutes , Operations Command , Air Force Material Command , Private Securities Litigation Reform Act , Annual Report , Quarterly Reports , Current Reports ,